• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血清褪黑素水平预测严重创伤性脑损伤患者的死亡率。

Serum melatonin levels in predicting mortality in patients with severe traumatic brain injury.

机构信息

Intensive Care Unit, Hospital Universitario de Canarias, Ofra s/n, La Laguna, Santa Cruz de Tenerife, 38320, Spain.

Intensive Care Unit, Hospital Universitario Nuestra Señora de Candelaria, Crta del Rosario s/n, Santa Cruz de Tenerife, 38010, Spain.

出版信息

Anaesth Crit Care Pain Med. 2021 Dec;40(6):100966. doi: 10.1016/j.accpm.2021.100966. Epub 2021 Oct 27.

DOI:10.1016/j.accpm.2021.100966
PMID:34718184
Abstract

PURPOSE

A secondary brain injury could appear after traumatic brain injury (TBI) due to neuroinflammation, oxidation and apoptosis. Higher levels of serum melatonin have been found on admission for TBI in non-surviving than in surviving patients. Thus, the objective of this study was to know serum melatonin levels during the first week of TBI in surviving and non-surviving patients, and to know if serum melatonin levels during the first week of TBI can be used to predict mortality.

METHODS

Patients with an isolated and severe TBI were included; that is, if they scored < 10 points in non-cranial aspects of Injury Severity Score and < 9 points in the Glasgow Coma Scale. We measured serum melatonin concentrations at days 1, 4 and 8 of TBI. Thirty-day mortality was the end-point study.

RESULTS

Lower serum melatonin levels were found in the surviving patients (n = 90) than in the non-survivors (n = 34) on days 1 (p < 0.001), 4 (p < 0.001), and 8 (p = 0.02) of TBI. Serum melatonin concentrations on days 1, 4, and 8 of TBI had an area under curve (95% Confidence Interval) for the prediction of 30-day mortality of 0.85 (0.77-0.91; p < 0.001), 0.82 (0.74-0.89; p < 0.001) and 0.71 (0.61-0.79; p = 0.06) respectively.

CONCLUSIONS

The new findings of this study were the presence of higher levels of serum melatonin on days 1, 4 and 8 of TBI in non-survivors than in survivors, and the ability to predict 30-day mortality for serum melatonin levels measured at these time points. However, more research is necessary to confirm our results.

摘要

目的

继发性脑损伤可能由于神经炎症、氧化和细胞凋亡而在创伤性脑损伤(TBI)后出现。在 TBI 患者中,入院时血清褪黑素水平较高的非幸存者比幸存者高。因此,本研究的目的是了解 TBI 存活和非存活患者在发病第一周的血清褪黑素水平,并了解 TBI 发病第一周的血清褪黑素水平是否可用于预测死亡率。

方法

纳入了孤立性严重 TBI 患者;即,如果他们的损伤严重程度评分(ISS)非颅部分<10 分,格拉斯哥昏迷量表(GCS)<9 分。我们在 TBI 第 1、4 和 8 天测量血清褪黑素浓度。30 天死亡率是本研究的终点。

结果

TBI 第 1、4 和 8 天,存活患者(n=90)的血清褪黑素水平低于非存活患者(n=34)(p<0.001)。TBI 第 1、4 和 8 天的血清褪黑素浓度对 30 天死亡率的预测的曲线下面积(95%置信区间)分别为 0.85(0.77-0.91;p<0.001)、0.82(0.74-0.89;p<0.001)和 0.71(0.61-0.79;p=0.06)。

结论

本研究的新发现是,在 TBI 第 1、4 和 8 天,非幸存者的血清褪黑素水平高于幸存者,并且可以通过测量这些时间点的血清褪黑素水平来预测 30 天死亡率。然而,需要进一步的研究来证实我们的结果。

相似文献

1
Serum melatonin levels in predicting mortality in patients with severe traumatic brain injury.血清褪黑素水平预测严重创伤性脑损伤患者的死亡率。
Anaesth Crit Care Pain Med. 2021 Dec;40(6):100966. doi: 10.1016/j.accpm.2021.100966. Epub 2021 Oct 27.
2
Traumatic Brain Injury Patients Mortality and Serum Total Antioxidant Capacity.创伤性脑损伤患者的死亡率与血清总抗氧化能力
Brain Sci. 2020 Feb 18;10(2):110. doi: 10.3390/brainsci10020110.
3
Serum melatonin levels in survivor and non-survivor patients with traumatic brain injury.创伤性脑损伤幸存者和非幸存者患者的血清褪黑素水平。
BMC Neurol. 2017 Jul 19;17(1):138. doi: 10.1186/s12883-017-0922-2.
4
Persistently High Serum Substance P Levels and Early Mortality in Patients with Severe Traumatic Brain Injury.严重创伤性脑损伤患者血清中持续高水平的 P 物质与早期死亡率。
World Neurosurg. 2019 Dec;132:e613-e617. doi: 10.1016/j.wneu.2019.08.064. Epub 2019 Aug 20.
5
Low blood caspase-8 levels in survivor patients of traumatic brain injury.创伤性脑损伤幸存者患者的血液 caspase-8 水平较低。
Neurol Sci. 2021 Dec;42(12):5065-5070. doi: 10.1007/s10072-021-05205-2. Epub 2021 Mar 23.
6
High blood Fas concentrations in non-survivor patients with traumatic brain injury.创伤性脑损伤患者中非幸存者的高 Fas 浓度。
Intern Emerg Med. 2022 Oct;17(7):2113-2118. doi: 10.1007/s11739-022-03023-8. Epub 2022 Jun 27.
7
Higher Serum Melatonin Levels during the First Week of Malignant Middle Cerebral Artery Infarction in Non-Surviving Patients.非存活患者恶性大脑中动脉梗死第一周血清褪黑素水平较高。
Brain Sci. 2019 Nov 28;9(12):346. doi: 10.3390/brainsci9120346.
8
Nonsurviving Patients with Severe Traumatic Brain Injury Have Maintained High Serum sCD40L Levels.严重创伤性脑损伤的未存活患者保持高血清 sCD40L 水平。
World Neurosurg. 2019 Jun;126:e1537-e1541. doi: 10.1016/j.wneu.2019.03.179. Epub 2019 Mar 27.
9
Serum soluble CD40 Ligand levels are associated with severity and mortality of brain trauma injury patients.血清可溶性 CD40 配体水平与颅脑创伤患者的严重程度和死亡率相关。
Thromb Res. 2014 Oct;134(4):832-6. doi: 10.1016/j.thromres.2014.07.034. Epub 2014 Aug 2.
10
High Serum Soluble Fas Ligand Levels in Non-survivor Traumatic Brain Injury Patients.血清可溶性 Fas 配体水平在创伤性脑损伤患者非幸存者中的升高。
Neurocrit Care. 2021 Aug;35(1):249-254. doi: 10.1007/s12028-020-01158-0. Epub 2021 Jan 6.

引用本文的文献

1
Neurochemical Insights into the Role of Tryptophan Metabolites and Kynurenine Pathway in Insomnia and its Psychological and Neurological Comorbidities.色氨酸代谢物和犬尿氨酸途径在失眠及其心理和神经共病中作用的神经化学见解
Mol Neurobiol. 2025 Jul 19. doi: 10.1007/s12035-025-05210-y.
2
Antioxidant and Anti-Inflammatory Properties of Melatonin in Secondary Traumatic Brain Injury.褪黑素在继发性创伤性脑损伤中的抗氧化和抗炎特性
Antioxidants (Basel). 2024 Dec 28;14(1):25. doi: 10.3390/antiox14010025.
3
Traumatic Brain Injury, Sleep, and Melatonin-Intrinsic Changes with Therapeutic Potential.
创伤性脑损伤、睡眠与具有治疗潜力的褪黑素内在变化
Clocks Sleep. 2023 Apr 6;5(2):177-203. doi: 10.3390/clockssleep5020016.
4
The Putative Role of Neuroinflammation in the Interaction between Traumatic Brain Injuries, Sleep, Pain and Other Neuropsychiatric Outcomes: A State-of-the-Art Review.神经炎症在创伤性脑损伤、睡眠、疼痛及其他神经精神性结局相互作用中的假定作用:最新综述
J Clin Med. 2023 Feb 23;12(5):1793. doi: 10.3390/jcm12051793.